Eve Burstein
Stock Analyst at Bernstein
(4.46)
# 1,110
Out of 4,517 analysts
99
Total ratings
70%
Success rate
27.5%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintained: Buy | $175 → $200 | $155.00 | +29.03% | 9 | Jul 2, 2026 | |
| A Agilent Technologies | Initiated Coverage: Buy | $125 → $155 | $136.10 | +13.89% | 12 | Jun 25, 2026 | |
| ILMN Illumina | Initiated Coverage: Hold | $90 → $185 | $190.25 | -2.76% | 13 | Jun 25, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | $115 | $111.70 | +2.95% | 10 | Jun 25, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Hold | $570 → $520 | $543.19 | -4.27% | 14 | Jun 25, 2026 | |
| WAT Waters | Initiated Coverage: Buy | $360 → $435 | $378.19 | +15.02% | 11 | Jun 25, 2026 | |
| NTRA Natera | Initiated Coverage: Buy | $205 → $310 | $269.83 | +14.89% | 9 | Jun 25, 2026 | |
| AVTR Avantor | Initiated Coverage: Hold | $13 → $11 | $11.26 | -6.75% | 10 | Jun 25, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $1.5 → $1.7 | $1.49 | +14.09% | 10 | Aug 8, 2025 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Sell | €194.00 | €247.00 | n/a | 1 | Jan 6, 2025 |
Guardant Health
Jul 2, 2026
Maintained: Buy
Price Target: $175 → $200
Current: $155.00
Upside: +29.03%
Agilent Technologies
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $125 → $155
Current: $136.10
Upside: +13.89%
Illumina
Jun 25, 2026
Initiated Coverage: Hold
Price Target: $90 → $185
Current: $190.25
Upside: -2.76%
Revvity
Jun 25, 2026
Initiated Coverage: Hold
Price Target: $115
Current: $111.70
Upside: +2.95%
Thermo Fisher Scientific
Jun 25, 2026
Initiated Coverage: Hold
Price Target: $570 → $520
Current: $543.19
Upside: -4.27%
Waters
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $360 → $435
Current: $378.19
Upside: +15.02%
Natera
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $205 → $310
Current: $269.83
Upside: +14.89%
Avantor
Jun 25, 2026
Initiated Coverage: Hold
Price Target: $13 → $11
Current: $11.26
Upside: -6.75%
Pacific Biosciences of California
Aug 8, 2025
Maintained: Buy
Price Target: $1.5 → $1.7
Current: $1.49
Upside: +14.09%
Sartorius Aktiengesellschaft
Jan 6, 2025
Maintained: Sell
Price Target: €194.00
Current: €247.00
Upside: n/a